0

Coronary Risk Factors Collection
 141-160 of 1897 Articles
Articles |  1 September 2009
Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Trial
Katherine Esposito, MD, PhD; Maria Ida Maiorino, MD; Miryam Ciotola, MD; et al.
Ann Intern Med. 2009;151(5):306-314. doi:10.7326/0003-4819-151-5-200909010-00004
Academia and the Profession |  18 August 2009 FREE
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati, MD, DrPH; Douglas G. Altman, DSc; Jennifer Tetzlaff, BSc; et al.
Ann Intern Med. 2009;151(4):W-65-W-94. doi:10.7326/0003-4819-151-4-200908180-00136
Ideas and Opinions |  21 July 2009
Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction
Sonia Y. Angell, MD, MPH; Lynn Dee Silver, MD, MPH; Gail P. Goldstein, MPH; et al.
Ann Intern Med. 2009;151(2):129-134. doi:10.7326/0003-4819-151-2-200907210-00010
Articles |  7 July 2009 FREE
Effect of Telmisartan on Renal Outcomes: A Randomized Trial
Johannes F.E. Mann, MD; Roland E. Schmieder, MD; Leanne Dyal, MSc; et al.
Ann Intern Med. 2009;151(1):1-10. doi:10.7326/0003-4819-151-1-200907070-00122
Articles |  7 July 2009 FREE
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials
Rudy Bilous, MD; Nish Chaturvedi, MD; Anne Katrin Sjølie, MD; et al.
Ann Intern Med. 2009;151(1):11-20. doi:10.7326/0003-4819-151-1-200907070-00120
Articles |  16 June 2009
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
David J. Becker, MD; Ram Y. Gordon, MD; Steven C. Halbert, MD; et al.
Ann Intern Med. 2009;150(12):830-839. doi:10.7326/0003-4819-150-12-200906160-00006
Reviews |  16 June 2009
Narrative Review: Statin-Related Myopathy
Tisha R. Joy, MD; Robert A. Hegele, MD
Ann Intern Med. 2009;150(12):858-868. doi:10.7326/0003-4819-150-12-200906160-00009
Editorials |  16 June 2009
Balancing Randomized Trials With Anecdote
Paul S. Phillips, MD
Ann Intern Med. 2009;150(12):885-886. doi:10.7326/0003-4819-150-12-200906160-00014
Articles |  2 June 2009
Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Henry S. Kahn, MD; Yiling J. Cheng, MD, PhD; Theodore J. Thompson, MS; et al.
Ann Intern Med. 2009;150(11):741-751. doi:10.7326/0003-4819-150-11-200906020-00002
Reviews |  2 June 2009
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
James R. Sowers, MD; Adam Whaley-Connell, DO; Murray Epstein, MD
Ann Intern Med. 2009;150(11):776-783. doi:10.7326/0003-4819-150-11-200906020-00005
Academia and the Profession |  2 June 2009
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Nancy R. Cook, ScD; Paul M Ridker, MD
Ann Intern Med. 2009;150(11):795-802. doi:10.7326/0003-4819-150-11-200906020-00007
Ideas and Opinions |  2 June 2009
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori, MD, MSc; Mercè Fernández-Balsells, MD
Ann Intern Med. 2009;150(11):803-808. doi:10.7326/0003-4819-150-11-200906020-00008
Editorials |  2 June 2009
Predicting Risk for Diabetes: Choosing (or Building) the Right Model
William H. Herman, MD, MPH
Ann Intern Med. 2009;150(11):812-814. doi:10.7326/0003-4819-150-11-200906020-00010
Academia and the Profession |  19 May 2009
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
Ann M. O'Hare, MD; James S. Kaufman, MD; Kenneth E. Covinsky, MD, MPH; et al.
Ann Intern Med. 2009;150(10):717-724. doi:10.7326/0003-4819-150-10-200905190-00010
Articles |  21 April 2009 FREE
Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage
J. Michael McWilliams, MD, PhD; Ellen Meara, PhD; Alan M. Zaslavsky, PhD; et al.
Ann Intern Med. 2009;150(8):505-515. doi:10.7326/0003-4819-150-8-200904210-00005
Articles |  21 April 2009 FREE
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two Randomized Trials
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS; H. Gilbert Welch, MD, MPH
Ann Intern Med. 2009;150(8):516-527. doi:10.7326/0003-4819-150-8-200904210-00106
Articles |  21 April 2009
Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U.S. Men and Women of European Ancestry
Marilyn C. Cornelis, PhD; Lu Qi, MD, PhD; Cuilin Zhang, MD, PhD; et al.
Ann Intern Med. 2009;150(8):541-550. doi:10.7326/0003-4819-150-8-200904210-00008
Editorials |  21 April 2009 FREE
Communicating Drug Benefits and Risks Effectively: There Must Be a Better Way
Jerry Avorn, MD; William H. Shrank, MD, MSHS
Ann Intern Med. 2009;150(8):563-564. doi:10.7326/0003-4819-150-8-200904210-00012
Articles |  7 April 2009
Effect of Varying Levels of Disease Management on Smoking Cessation: A Randomized Trial
Edward F. Ellerbeck, MD, MPH; Jonathan D. Mahnken, PhD; A. Paula Cupertino, PhD; et al.
Ann Intern Med. 2009;150(7):437-446. doi:10.7326/0003-4819-150-7-200904070-00003
Articles |  7 April 2009
Triple-Combination Pharmacotherapy for Medically Ill Smokers: A Randomized Trial
Michael B. Steinberg, MD, MPH; Shelley Greenhaus, RN, MPH; Amy C. Schmelzer, MS; et al.
Ann Intern Med. 2009;150(7):447-454. doi:10.7326/0003-4819-150-7-200904070-00004
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)